Encess Pharmaceuticals Private Limited
About Encess Pharmaceuticals Private Limited
Data last updated:
Encess Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 15 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC319294.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sumit Kumar Verma and Chetna Verma.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 40 – A Pocket – R Dilshad Garden, New Delhi, Delhi, India – 110015.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Encess Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered Address40 – A Pocket – R Dilshad Garden, New Delhi, Delhi, India – 110015
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Encess Pharmaceuticals Private Limited
FY 2019 filings availableFinancial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Encess Pharmaceuticals Private Limited, buy the company report.
Board of directors of Encess Pharmaceuticals Private Limited
Encess Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Kumar Verma | Director | 15 Jun 2017 | 9 Years 4 Months | Current |
| Chetna Verma | Director | 15 Jun 2017 | 9 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Encess Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Encess Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Encess Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Encess Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Chetna Verma was appointed as Director on 15 Jun 2017.
Frequently asked questions
Encess Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other services, within the business services industry. It was incorporated on 15 June 2017 (9+ years old) and is registered under CIN U74999DL2017PTC319294.
Encess Pharmaceuticals has 2 current directors:
- Sumit Kumar Verma - Director
- Chetna Verma - Director
The latest financial statements of Encess Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Encess Pharmaceuticals is U74999DL2017PTC319294. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Encess Pharmaceuticals was incorporated on 15 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Chetna Verma was appointed as Director on 15 Jun 2017. Sumit Kumar Verma was appointed as Director on 15 Jun 2017.
The registered office of Encess Pharmaceuticals is at 40 – A Pocket – R Dilshad Garden, New Delhi, Delhi, India – 110015.
Encess Pharmaceuticals operates in the business services industry, in the other services segment.
The compliance status of Encess Pharmaceuticals is compliant as of 05 August 2026. The company is actively filing with the Registrar of Companies.
Encess Pharmaceuticals can be reached at its registered office: 40 – A Pocket – R Dilshad Garden, New Delhi, Delhi, India – 110015.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
